InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by LYNCH DANIEL, Director. Director active across 4 companies, notably SpringWorks Therapeutics, Inc.. Cumulatively, 10 reports have been logged. The latest transaction was disclosed on 8 June 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations10 total
07,200 shares0
Common Stock
SEC:0001562180-22-004992:0·
04,818 shares0
Common Stock
SEC:0001104659-22-063508:0·
02,803 shares0
Common Stock
SEC:0001628280-21-023471·
02,803 shares0
Common Stock
SEC:0001628280-21-023471:0·
04,353 shares0
Common Stock
SEC:0001562180-21-004349·
04,353 shares0
Common Stock
SEC:0001562180-21-004349:0·
01,106 shares0
Common Stock
SEC:0001104659-21-070515·
01,106 shares0
Common Stock
SEC:0001104659-21-070515:0·
10 of 10 declarations
About LYNCH DANIEL
Daniel Lynch is a Board Member at SpringWorks Therapeutics, Inc. and bluebird bio, Inc. He plays a key role in the governance of these companies, bringing his expertise in management and strategy. His involvement in the boards allows him to contribute to strategic decision-making and guide the companies toward a sustainable future.
